Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atricure Inc (NQ: ATRC )

28.42 -0.16 (-0.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 379,888
Open 28.86
Bid (Size) 25.64 (1)
Ask (Size) 34.90 (3)
Prev. Close 28.58
Today's Range 28.20 - 29.39
52wk Range 18.94 - 44.64
Shares Outstanding 45,882,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
From AtriCure, Inc.
Via Business Wire
AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
From AtriCure, Inc.
Via Business Wire

Performance

YTD
-19.54%
-19.54%
1 Month
+8.68%
+8.68%
3 Month
+23.57%
+23.57%
6 Month
-5.71%
-5.71%
1 Year
-32.89%
-32.89%

More News

Read More
Navigating 6 Analyst Ratings For AtriCure
Via Benzinga
Analyst Ratings For AtriCure
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For AtriCure
Via Benzinga
Key Takeaways From AtriCure Analyst Ratings
Via Benzinga
ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024
Via InvestorPlace
AtriCure Reports Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
From AtriCure, Inc.
Via Business Wire
Cracking The Code: Understanding Analyst Reviews For AtriCure
Via Benzinga
Recap: AtriCure Q4 Earnings
Via Benzinga
Earnings Scheduled For February 15, 2024
Via Benzinga
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
From AtriCure, Inc.
Via Business Wire
ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
AtriCure Reports First Quarter 2024 Financial Results
From AtriCure, Inc
Via Business Wire
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce First Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
Coinbase To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
From AtriCure, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.